Get the Stockscreener App
0.0775
44.02%
-0.061
After Hours:
.08
0.0025
+3.23%
T 2 Biosystems Inc stock is traded at $0.0775, with a volume of 131.34K.
It is down -44.02% in the last 24 hours and down -43.40% over the past month.
See More
Previous Close:
$0.1385
Open:
$0.1
24h Volume:
131.34K
Relative Volume:
13.12
Market Cap:
$N/A
Revenue:
$7.68M
Net Income/Loss:
$-42.95M
P/E Ratio:
-0.0121
EPS:
-6.4178
Net Cash Flow:
$-36.59M
1W Performance:
-44.02%
1M Performance:
-43.40%
6M Performance:
-93.36%
1Y Performance:
-95.82%
1-Day Range:
$0.0002
$0.11
1-Week Range:
$0.0002
$0.11
52-Week Range:
$0.0002
$0.165
T 2 Biosystems Inc Stock (TTOO) Company Profile
Name
T 2 Biosystems Inc
Sector
Industry
Phone
-
Address
-
Compare TTOO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.0775 | 0 | 7.68M | -42.95M | -36.59M | -6.4178 |
|
TMO
Thermo Fisher Scientific Inc
|
414.75 | 164.16B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.05 | 146.60B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
514.61 | 42.89B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.99 | 35.02B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
160.63 | 28.16B | 15.50B | 1.33B | 2.16B | 7.34 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Nov-26-19 | Downgrade | Janney | Buy → Neutral |
| Aug-01-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jul-31-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-31-19 | Downgrade | Janney | Buy → Neutral |
| May-16-19 | Initiated | Alliance Global Partners | Buy |
| Mar-08-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-01-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| May-30-18 | Reiterated | H.C. Wainwright | Buy |
| May-29-18 | Reiterated | WBB Securities | Strong Buy |
| Mar-29-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Goldman | Neutral |
| Oct-18-17 | Initiated | H.C. Wainwright | Buy |
| Mar-15-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-10-16 | Resumed | Leerink Partners | Mkt Perform |
| Nov-02-16 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-20-16 | Upgrade | WBB Securities | Buy → Strong Buy |
| Jun-22-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
| Apr-12-16 | Reiterated | Canaccord Genuity | Buy |
| Feb-17-16 | Initiated | WBB Securities | Speculative Buy |
View All
T 2 Biosystems Inc Stock (TTOO) Latest News
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Investor Network: T2 Biosystems, Inc. to Host Earnings Call - ACCESS Newswire
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Above 50-Day Moving Average – Should You Sell? - Defense World
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Wall Street Zen Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200 Day Moving Average – Should You Sell? - Defense World
StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - The AM Reporter
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems (NASDAQ:TTOO) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World
T2 Biosystems (NASDAQ:TTOO) Shares Pass Below 200-Day Moving Average – Time to Sell? - The AM Reporter
T2 Biosystems Delays Yearly Report Filing - TipRanks
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - Yahoo Finance
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - The AM Reporter
T2 Biosystems, Inc. to Host Earnings Call - ACCESS Newswire
Blood Culture Screening Devices Market Rewriting its Growth Cycle | bioMérieux SA, OpGen, T2 Biosystems - Newstrail
T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com - Defense World
T2 Biosystems Announces Major Reduction-In-Force and Plans for Potential Sale - Defense World
T2 Biosystems initiates major layoffs, seeks asset sale By Investing.com - Investing.com Australia
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com India
Massachusetts-based medical diagnostics firm lays off ‘substantially all' employees - NBC Boston
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Revenue Breakdown – OTC:TTOO - TradingView
T2 Biosystems to be delisted from Nasdaq - MSN
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results - br.ADVFN.com
T2 Biosystems stock plunges to 52-week low of $0.22 - MSN
T2 Biosystems to be delisted from Nasdaq By Investing.com - Investing.com Canada
T2 Biosystems Gets Nasdaq Delisting Notice; Shares Down - marketscreener.com
Navigating TTOO’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
T2 Biosystems Receives Delisting Notice from Nasdaq, Plans to Move to OTC MarketsLEXINGTON, Massachusetts–(BUSINESS WIRE)–T2 Biosystems, Inc. (NASDAQ: TTOO) announced today that it has received notice from the Nasdaq Stock Market LLC (“Na - Defense World
Analyzing Ratios: T2 Biosystems Inc (TTOO)’s Financial Story Unveiled - The Dwinnex
T2 Biosystems Inc [TTOO] Shares Fall Approximately -95.14% Over the Year - Knox Daily
T 2 Biosystems Inc Stock (TTOO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.16%
Cap:
|
Volume (24h):